Lora Dimitrova

1.4k total citations
12 papers, 96 citations indexed

About

Lora Dimitrova is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Lora Dimitrova has authored 12 papers receiving a total of 96 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pathology and Forensic Medicine and 3 papers in Cancer Research. Recurrent topics in Lora Dimitrova's work include Lymphoma Diagnosis and Treatment (4 papers), Epigenetics and DNA Methylation (3 papers) and Cancer-related gene regulation (3 papers). Lora Dimitrova is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), Epigenetics and DNA Methylation (3 papers) and Cancer-related gene regulation (3 papers). Lora Dimitrova collaborates with scholars based in Germany, France and Australia. Lora Dimitrova's co-authors include Michael Hummel, Dido Lenze, Wolfram Gronwald, Peter J. Oefner, Franziska Taruttis, Rainer Spang, Katja Dettmer, Jörg Reinders, Julia C. Engelmann and Ahmed Haider and has published in prestigious journals such as PLoS ONE, Journal of Investigative Dermatology and Journal of Proteome Research.

In The Last Decade

Lora Dimitrova

12 papers receiving 96 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lora Dimitrova Germany	6	64	25	22	19	15	12	96
Peter‐Martin Bruch Germany	7	71 1.1×	17 0.7×	26 1.2×	21 1.1×	24 1.6×	15	126
Asako Ooe Japan	4	57 0.9×	39 1.6×	17 0.8×	3 0.2×	17 1.1×	8	108
Melissa E. Ko United States	4	58 0.9×	18 0.7×	21 1.0×	9 0.5×	26 1.7×	7	111
Mai Q. Nguyen United States	6	91 1.4×	23 0.9×	12 0.5×	20 1.1×	38 2.5×	6	123
Deyaa Adib United States	6	34 0.5×	10 0.4×	38 1.7×	16 0.8×	35 2.3×	16	85
Françoise Révillion France	6	75 1.2×	23 0.9×	5 0.2×	22 1.2×	32 2.1×	11	105
Maria Andrianova United States	5	65 1.0×	53 2.1×	30 1.4×	6 0.3×	16 1.1×	8	103
Dina Levi Canada	6	51 0.8×	32 1.3×	27 1.2×	34 1.8×	22 1.5×	10	138
Ana P. Kutschat United States	7	98 1.5×	17 0.7×	27 1.2×	20 1.1×	25 1.7×	9	134
Javier R. Arango Spain	3	71 1.1×	15 0.6×	38 1.7×	24 1.3×	21 1.4×	3	113

Countries citing papers authored by Lora Dimitrova

Since Specialization

Citations

This map shows the geographic impact of Lora Dimitrova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lora Dimitrova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lora Dimitrova more than expected).

Fields of papers citing papers by Lora Dimitrova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lora Dimitrova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lora Dimitrova. The network helps show where Lora Dimitrova may publish in the future.

Co-authorship network of co-authors of Lora Dimitrova

This figure shows the co-authorship network connecting the top 25 collaborators of Lora Dimitrova. A scholar is included among the top collaborators of Lora Dimitrova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lora Dimitrova. Lora Dimitrova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Schmidt, Carolin, Robert Stöhr, Lora Dimitrova, et al.. (2024). Quality-Assured Analysis of PIK3CA Mutations in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer Tissue. Journal of Molecular Diagnostics. 26(7). 624–637. 1 indexed citations

Fairley, Jennifer A., Tony Badrick, Marc G. Denis, et al.. (2023). Implementation of circulating tumour DNA multi-target mutation testing in plasma: a perspective from an external quality assessment providers’ survey. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(4). 717–722. 5 indexed citations

Pohl, Sandra, Lora Dimitrova, Korinna Jöhrens, et al.. (2023). Update on quality assurance in neuropathology: Summary of the round robin trials on TERT promoter mutation, H3-3A mutation, 1p/19q codeletion, and KIAA1549::BRAF fusion testing in Germany in 2020 and 2021. Clinical Neuropathology. 42(5). 112–121. 1 indexed citations

Vollbrecht, Claudia, Inga Hoffmann, Annika Lehmann, et al.. (2022). Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 482(4). 697–706. 8 indexed citations

López, Cristina, Rabea Wagener, Katja Dettmer, et al.. (2020). Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma model. BMC Cancer. 20(1). 427–427. 4 indexed citations

Dimitrova, Lora, Erika Gebel Berg, Franziska Taruttis, et al.. (2019). Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma. BMC Cancer. 19(1). 322–322. 10 indexed citations

Lenze, Dido, et al.. (2019). DZNep-mediated apoptosis in B-cell lymphoma is independent of the lymphoma type, EZH2 mutation status and MYC, BCL2 or BCL6 translocations. PLoS ONE. 14(8). e0220681–e0220681. 12 indexed citations

Reinders, Jörg, Katja Dettmer, Lora Dimitrova, et al.. (2017). Comprehensive Metaboproteomics of Burkitt’s and Diffuse Large B-Cell Lymphoma Cell Lines and Primary Tumor Tissues Reveals Distinct Differences in Pyruvate Content and Metabolism. Journal of Proteome Research. 16(3). 1105–1120. 21 indexed citations

Haider, Ahmed, Reinhard Ullmann, Michael Hummel, et al.. (2016). Inactivation of RUNX3/p46 Promotes Cutaneous T-Cell Lymphoma. Journal of Investigative Dermatology. 136(11). 2287–2296. 13 indexed citations

10.

Seitz, Volkhard, Thomas K. H. Chang, Karin Zimmermann, et al.. (2011). Classical Hodgkin's lymphoma shows epigenetic features of abortive plasma cell differentiation. Haematologica. 96(6). 863–870. 17 indexed citations

11.

Matthes, Eckart, Christine Lehmann, Yong Wu, et al.. (2005). Potent Inhibitory Activity of Chimeric Oligonucleotides Targeting Two Different Sites of Human Telomerase. Oligonucleotides. 15(4). 255–268. 3 indexed citations

12.

Dimitrova, Lora, et al.. (1963). [Clinical picture and pathogenesis of Gianotti-Crosti syndrome].. PubMed. 37. 14–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact